Pemafibrate is a selective peroxisome proliferator-activated receptor alpha (PPARα) modulator, or SPPARMα, primarily utilized as a therapeutic agent for the treatment of hypertriglyceridemia. This category… Read more

![Chemical structure of (R)-2-(3-((Benzo[d]oxazol-2-yl(3-(4-hydroxyphenoxy)propyl)amino)methyl)phenoxy)butanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F848260-34-4-R-2-3-Benzodoxazol-2-yl3-4-hydroxyphenoxypropylaminomethylphenoxybutanoic-Acid.png&w=3840&q=75)

![Chemical structure of 3-((Benzo[d]oxazol-2-yl(3-(4-methoxyphenoxy)propyl)amino)methyl)phenol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F848260-89-9-3-Benzodoxazol-2-yl3-4-methoxyphenoxypropylaminomethylphenol.png&w=3840&q=75)












Pemafibrate is a selective peroxisome proliferator-activated receptor alpha (PPARα) modulator, or SPPARMα, primarily utilized as a therapeutic agent for the treatment of hypertriglyceridemia. This category offers high-quality reference standards essential for the rigorous analytical testing, method validation, and quality control of this active pharmaceutical ingredient. Laboratories rely on these materials, including identified impurities and metabolites, to support comprehensive impurity profiling during drug development and stability studies. The collection also features stable isotope labelled compounds, which serve as crucial internal standards for accurate quantification in complex bioanalytical assays such as LC-MS/MS. By providing access to enantiomers, synthetic derivatives, and degradation products, this selection supports researchers in maintaining regulatory compliance and ensuring the consistency of testing protocols for this important lipid-lowering medication.